Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118049 · ClinicalTrials.gov registry record · NA
Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment
A NA study, sponsored by Hartford Hospital.
- Completed
- Registry status
- NA
- Development phase
- 141
- Enrollment target
NCT04118049 is a NA study that has completed, run by Hartford Hospital. The registered enrollment target is 141 participants.
The verdict
NCT04118049, a NA study, has completed, sponsored by Hartford Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 141 participants
- Enrollment target
Study Summary
In this study, the investigators are evaluating the effect of vaginal probiotics on the bothersome side effects of pessary use and the impact on the vaginal microenvironment (lactobacilli, anaerobic bacteria, mobiluncus bacteria, WBCs, cellular debris, epithelial cells, and BVAB-1), and inflammatory environment (cytokines).
Interventions
- OTHER Standard Care
- OTHER BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2019-10-30 |
| Est. Completion | 2021-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04118049
The ClinicalTrials.gov registry entry for NCT04118049 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hartford Hospital, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT04118049 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04118049 about?
NCT04118049 is a clinical study titled "Vaginal Probiotics and Pessaries and Their Impact on the Vaginal Microenvironment". In this study, the investigators are evaluating the effect of vaginal probiotics on the bothersome side effects of pessary use and the impact on the vaginal microenvironment (lactobacilli, anaerobic bacteria, mobiluncus bacteria, WBCs, cellular debris, epithelial cells, and BVAB-1), and inflammatory...
What is the current status of trial NCT04118049?
This trial is currently completed. It is a NA study. The enrollment target is 141 participants. The study started on 2019-10-30. Estimated completion is 2021-05-30.
What interventions are being tested in trial NCT04118049?
The interventions under investigation include: Standard Care (OTHER), BiopHreshTM vaginal probiotic supplement (Good Clean Love, Inc. Eugene, OR) and RestoreTM gel. (OTHER).
Who is sponsoring clinical trial NCT04118049?
This trial is sponsored by Hartford Hospital, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.